| Company name | Cuorips Inc. | |
|---|---|---|
| Location (MAP) |
■Head office (registered address) 507, Nihonbashi Life Science Building 2, 3-11-5 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023 ■Osaka Laboratory E503, 5F Life System Building, 1-3 Yamadaoka, Suita, Osaka 565-0871 ■Click-1 MinohSenri Building 9F, 3-4-17, Senbahigashi, Minoh, Osaka 562-0035, Japan |
|
| Established | March 21, 2017 | |
| Content of Business | Development and commercialization of iPS cell-derived cardiomyocyte sheets | |
| Direstors | President and CEO Takayuki Kusanagi Executive vice-president Manabu Inoue Director of the Board and CTO Yoshiki Sawa Director of the Board Tadashi Samejima Director of the Board Ryohei Shimazaki Audit & Supervisory Board Member Toru Sumiyoshi Audit & Supervisory Board Member Kotaro Yamamoto Audit & Supervisory Board Member Shinji Abe |
|
| Employees | 43 (as of March 2022) | |
| Principal shareholders | Daiichi Sankyo Co., Ltd., Kyoto University Innovation Capital Co., Ltd., Terumo Corp., Taiko Pharmaceutical Co., Ltd., Mitsubishi Corp., StemCell Institute. and DAI-DAN Co.,Ltd. | |
| Inquiry | info@cuorips.co.jp | |